Session covers what the various stakeholders (i.e., auditors, regulators, management, and the board) should consider as internal controls to mitigate issues related to the opioid crisis. Both public and private company expectations will be represented.
• Overview of the scope of the crisis;
• Understand areas of risk needing internal controls
• Learn some specific examples of monitoring for fraud and abuse related to the opioid crisis